About: Reinvigorating Antibiotics and Diagnostic Innovation (READI) Act

Facets (new session)
Description
Metadata
Settings
- Rule:
- Inverse Functional Properties:
- "Same As":

About: Reinvigorating Antibiotics and Diagnostic Innovation (READI) Act Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : dbpedia.demo.openlinksw.com associated with source document(s)
QRcode icon

http://dbpedia.demo.openlinksw.com/describe/?url=http%3A%2F%2Fdbpedia.org%2Fresource%2FReinvigorating_Antibiotics_and_Diagnostic_Innovation_%28READI%29_Act&invfp=IFP_OFF&sas=SAME_AS_OFF

The Reinvigorating Antibiotics and Diagnostic Innovation (READI) Act (H.R. 1840) is a bipartisan bill introduced in the U.S. House of Representatives by Congressman Erik Paulsen (R-MN) and Congressman Mike Thompson (D-CA). The bill would give a tax credit to organizations that create new antibiotics and "rapid diagnostic tests" that treat serious or life-threatening infections. According to the Infectious Diseases Society of America, the legislation's tax credit is modeled after the credit offered under the Orphan Drug Act for treatments of rare diseases.

Attributes	Values
rdfs:label	Reinvigorating Antibiotics and Diagnostic Innovation (READI) Act (en)
rdfs:comment	The Reinvigorating Antibiotics and Diagnostic Innovation (READI) Act (H.R. 1840) is a bipartisan bill introduced in the U.S. House of Representatives by Congressman Erik Paulsen (R-MN) and Congressman Mike Thompson (D-CA). The bill would give a tax credit to organizations that create new antibiotics and "rapid diagnostic tests" that treat serious or life-threatening infections. According to the Infectious Diseases Society of America, the legislation's tax credit is modeled after the credit offered under the Orphan Drug Act for treatments of rare diseases. (en)
name	Reinvigorating Antibiotics and Diagnostic Innovation Act (en)
dcterms:subject	United States proposed federal taxation legislation Proposed legislation of the 115th United States Congress Proposed legislation of the 114th United States Congress United States proposed federal health legislation
Wikipage page ID	53697766 (xsd:integer)
Wikipage revision ID	1102165943 (xsd:integer)
Link from a Wikipage to another Wikipage	United States proposed federal taxation legislation San Francisco General Hospital Antimicrobial resistance Republican Party (United States) United States House Committee on Ways and Means Tax credit Minnesota Antibiotic Centers for Disease Control and Prevention Erik Paulsen Food and Drug Administration Proposed legislation of the 115th United States Congress Proposed legislation of the 114th United States Congress United States proposed federal health legislation Authorization bill Infectious Diseases Society of America Mike Thompson (California politician) Orphan Drug Act of 1983 User fee Tax reform
Link from a Wikipage to an external page	https://www.cdc.gov/drugresistance/ https://www.congress.gov/bill/115th-congress/house-bill/1840/actions https://www.who.int/mediacentre/factsheets/antibiotic-resistance/en/
sameAs	Reinvigorating Antibiotics and Diagnostic Innovation (READI) Act Reinvigorating Antibiotics and Diagnostic Innovation (READI) Act
sponsored by	Erik Paulsen
dbp:wikiPageUsesTemplate	dbt:Infobox_United_States_federal_proposed_legislation dbt:Reflist dbt:USBill
introducedby	Erik Paulsen (en)
introduceddate	2017-03-30 (xsd:date)
introducedin	House (en)
committees	United States House Committee on Ways and Means
fullname	To amend the Internal Revenue Code of 1986 to allow a credit against tax for clinical testing expenses for qualified infectious disease drugs and rapid diagnostic tests. (en)
has abstract	The Reinvigorating Antibiotics and Diagnostic Innovation (READI) Act (H.R. 1840) is a bipartisan bill introduced in the U.S. House of Representatives by Congressman Erik Paulsen (R-MN) and Congressman Mike Thompson (D-CA). The bill would give a tax credit to organizations that create new antibiotics and "rapid diagnostic tests" that treat serious or life-threatening infections. According to Politico, "To encourage research and development, the bill would provide a new 50 percent tax credit for the clinical testing expenses of new antibiotics that treat serious or life-threatening infections and rapid infectious disease diagnostic tests." According to the Infectious Diseases Society of America, the legislation's tax credit is modeled after the credit offered under the Orphan Drug Act for treatments of rare diseases. Paulsen is co-chair of the Congressional Medical Technology Caucus. (en)
introduced in the	115 (xsd:integer)
leghisturl	https://www.congress.gov/bill/115th-congress/house-bill/1840/actions
number of co-sponsors	5 (xsd:integer)
prov:wasDerivedFrom	wikipedia-en:Reinvigorating_Antibiotics_and_Diagnostic_Innovation_(READI)_Act?oldid=1102165943&ns=0
page length (characters) of wiki page	5967 (xsd:nonNegativeInteger)
foaf:isPrimaryTopicOf	wikipedia-en:Reinvigorating_Antibiotics_and_Diagnostic_Innovation_(READI)_Act
is Link from a Wikipage to another Wikipage of	List of bills in the 115th United States Congress
is foaf:primaryTopic of	wikipedia-en:Reinvigorating_Antibiotics_and_Diagnostic_Innovation_(READI)_Act

Faceted Search & Find service v1.17_git139 as of Feb 29 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 08.03.3330 as of Mar 19 2024, on Linux (x86_64-generic-linux-glibc212), Single-Server Edition (378 GB total memory, 67 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software